KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United…
The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for…
Listed in the prestigious international academic journal, MDPI 'Prosthesis' SEOUL, South Korea, Aug. 6, 2025 /PRNewswire/ -- Osstem Implants, the…
The new interactive guideline tool represents a major format change for gold-standard NCCN Guidelines. PLYMOUTH MEETING, Pa., June 24, 2025…
LEUVEN, BELGIUM – Today, Green NCAP announces the formation of the Sino- European Automotive Carbon Footprint Mutual Recognition Working Group.…